University of Montpellier, France
Recent studies from France and the United States add new data to HIV/AIDS research
Published in Medicine and Law Weekly, August 25th, 2006
Study 1: HAART susceptibilities were determined for HIV-1 non-B subtypes.
According to recent research from France, "Most studies on antiretroviral (ARV) resistance of human immunodeficiency virus (HIV) have been done on subtype B which only represent a limited proportion of infections worldwide." A study was conducted to understand "baseline susceptibilities to ARVs in non-B strains."
"To explore in greater detail possible intrinsic resistance to antiretroviral drugs in non-B subtypes, phenotypic resistance was tested in 35 non-B (A, D, F. G. J;...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Alnylam Pharmaceuticals
Alnylam reports loss of $0.31 per share - Aomori Municipal Hospital, Aomori, Japan
Coronary artery bypass grafting using an abdominal artery as an inflow is described - BioMag
BioMag files application for a multi-assay diagnostic system designed for blood banks - Biomedical Primate Research Center, Rijswijk, Netherlands
Relative neutralization sensitivity/resistance is HIV-1 type B isolate reproducible property - Biosite
Biosite notes 45% increase in sales of cardiovascular products - Business & Finance
Chemed reports second-quarter 2006 results - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
